Alnylam Pharmaceuticals, Inc. earnings per share and revenue

ALNY earnings per share for the last quarter are -0.65 USD whereas the estimation was -0.59 USD which accounts for -9.78% surprise. Company revenue for the same period amounts to 593.17 M USD despite the estimated figure of 582.61 M USD. Estimated earnings per share for the next quarter are -0.94 USD, and revenue is expected to reach 589.96 M USD. Also watch annual changes over time to get a bigger picture of ALNY earnings per share and revenue dynamics.